RHBDF2 p.Arg412Trp
c.1234C>T · rs1315536442 · VCV2678344
Computational evidence
| Protein change | ||
| AlphaMissense | 0.347 | ambiguous |
|---|---|---|
| REVEL | 0.283 | benign-leaning |
| SaProt | LLR -5.69 | tolerated |
| ⇒ REVEL and SaProt both call this tolerated; AlphaMissense is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>C here scores Δ0.31 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 0.89 | GERP -1.6, phastCons 1 |
| Regional constraint | o/e 0.84 | unconstrained · MANE · 7,466 bp · p 2.1e-05 · regional, not allelic |
| Overall | ||
| CADD | 23.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R441W vs ClinVar R412W) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,474 |
| South Asiangrpmax | 0.0011% | 91,072 |
| European (non-Finnish) | 0.000509% | 196,640 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- RHBDF2
- Protein
- p.Arg412Trp
- Coding
- c.1234C>T
- MANE Select
- NM_001005498
- dbSNP
- rs1315536442
- Type
- single nucleotide variant
- Location
- chr17:76474798 (GRCh38)
- Gene constraint
- LOEUF 0.545 · pLI 0.15 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 67.53 · 5 PDB
Disease context
palmoplantar keratoderma-esophageal carcinoma syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Palmoplantar keratoderma-esophageal carcinoma syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Adult
Similar variants
- RHBDF2 p.Arg412Gln Conflicting classifications of pathogenicity ★ ⚠ same residue
- RHBDF2 p.Ile157Thr Pathogenic/Likely pathogenic ★★ ⚠ same condition
- RHBDF2 c.151-27G>T Uncertain significance ★★ ⚠ same condition
- RHBDF2 c.151-86G>A Uncertain significance ★★ ⚠ same condition
- RHBDF2 p.Ala397Ser Uncertain significance ★★ ⚠ same condition
- RHBDF2 p.Ala725Val Uncertain significance ★★ ⚠ same condition
- RHBDF2 p.Arg113His Uncertain significance ★★ ⚠ same condition
- RHBDF2 p.Arg235Trp Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rhbdf2-p-arg412trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown